Stocks
Health Care
teva
Teva Pharmaceutical Industries
TEL AVIV STOCK EXCHANGE: TEVA
+0.11 (+0.37%)
30.23
USD
At close at Apr 01, 20:39 UTC
Income Statement
Revenue
16.54B
Gross Profit
8.06B
Operating Income
-315.00M
Pretax Income
1.22B
Net Income
-1.64B
EBITDA
1.08B
EBIT
17.00M
Earnings Per Share
-1.45
Balance Sheet
Cash & Cash Equivalents
2.97B
Total Debt
19.05B
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
6.55B
Book Value Per Share
5.8
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.